medvi glp-1 is showing what a new kind of company can look like A telehealth platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B Doctor-Guided Medical Weight Loss Solutions
Description
Infant gastrointestinal absorption differs markedly from adults
Some platforms advertise a low entry price and quietly increase costs at every tier

Newer studies however, do not support the contention of a generalized defect in nutrient-related GLP-1 secretory responses in people with T2D, but rather suggest that the inter-individual differences in GLP-1 secretion, age of patients, duration of diabetes, concomitant drug therapy, and other variables play a role, and preclude definitive conclusions that diabetes is invariably associated with reduced GLP-1 secretion [22]

In comparison, participants who took part in the behavioural weight-loss programmes and did not take any weight-loss medicines, lost 5.1kg on average during the programme

(Ali et al

This critical biological process confirms Gaining Weight on GLP-1 is a complex biological reaction, not a sign of personal failure whatsoever
